Literature DB >> 16734976

Development of vaccines against bovine tuberculosis.

P J Hogarth1, R G Hewinson, H M Vordermeier.   

Abstract

Bovine tuberculosis caused by Mycobacterium bovis remains an economically important problem in Great Britain with potential zoonotic consequences, and the incidence is rising exponentially. In 1997 an independent scientific review recommended that the best option for disease control in Great Britain was the development of a cattle vaccine. Bovine tuberculosis remains a significant problem in countries of the developing world. Indeed, more than 94% of the world's population live in countries in which the control of bovine tuberculosis in buffalos or cattle is limited or absent. Effective vaccination strategies would have a major impact in countries that cannot afford expensive test and slaughter-based control strategies. Here, we present a review of progress toward that goal, and discuss how this progress has shaped our research strategy for the development of a vaccine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16734976     DOI: 10.1211/jpp.58.6.0005

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  6 in total

1.  Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish.

Authors:  J C Hope; M L Thom; M McAulay; E Mead; H M Vordermeier; D Clifford; R G Hewinson; B Villarreal-Ramos
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

2.  Development of a skin test for bovine tuberculosis for differentiating infected from vaccinated animals.

Authors:  Adam O Whelan; Derek Clifford; Bhagwati Upadhyay; Eleanor L Breadon; James McNair; Glyn R Hewinson; Martin H Vordermeier
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

3.  Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection.

Authors:  Ming Zhang; Chunsheng Dong; Sidong Xiong
Journal:  Hum Vaccin Immunother       Date:  2016-12-14       Impact factor: 3.452

4.  Adjuvants induce distinct immunological phenotypes in a bovine tuberculosis vaccine model.

Authors:  H Martin Vordermeier; Gillian S Dean; Ida Rosenkrands; Else M Agger; Peter Andersen; Daryan A Kaveh; R Glyn Hewinson; Philip J Hogarth
Journal:  Clin Vaccine Immunol       Date:  2009-07-29

5.  Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge.

Authors:  Daryan A Kaveh; Véronique S Bachy; R Glyn Hewinson; Philip J Hogarth
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

6.  Integrated computational prediction and experimental validation identifies promiscuous T cell epitopes in the proteome of Mycobacterium bovis.

Authors:  Damien Farrell; Gareth Jones; Christopher Pirson; Kerri Malone; Kevin Rue-Albrecht; Anthony J Chubb; Martin Vordermeier; Stephen V Gordon
Journal:  Microb Genom       Date:  2016-08-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.